← SynDRA
PIPOTIAZINE
SynDRA canonical compound SYN0008418 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | DRD1 | DRD2 | HTR1A | HTR2A |
|---|
| Mechanism of action | dopamine receptor antagonist |
|---|
| Indication | schizophrenia |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- DRD2
- DRD1
- HTR1A
- HTR2A
- DRD3
Mechanisms of action (all sources)
- DRD2 ANTAGONIST
- dopamine receptor antagonist
- serotonin receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- ADORA3
- SLC6A4
- SLC6A3
- SLC6A2
- PTGS1
- PGR
- PDE4A
- PDE3A
- OPRM1
- MAOA
- KDR
- KCNH2
- HTR2B
- HRH3
- F2
- ESR1
- DRD3
- CHRM2
- CHRM1
- AR
- ADRA2A
- ADRA1A
- TBXA2R
ATC classes
Cross-references
Synonyms
- Pipothiazine
- Pipotiazina
- Pipotiazinum
- Piportil
- Pipotiazinum [INN-Latin]
- Pipotiazina [INN-Spanish]
- UNII-L903J9JPYV
- L903J9JPYV
- 10-[3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl]-N,N-dimethylphenothiazine-2-sulfonamide
- Pipotiazine [INN:BAN]
- Piportil depot
- Piportil (TN)
- Pipotiazine (INN)
- EINECS 254-659-6
- AC1L1XY4
- SCHEMBL123275
- GTPL7557
- CHEMBL398880
- BDBM81798
- DTXSID40192913
- ZINC3813024
- BCP23973
- PDSP2_000525
- PDSP1_000527
- NSC_62867
- AKOS030527554
- DB01621
- ACM39860996
- pipotiazin
- RP-19366
- RefChem:863632
- DTXCID80115404
- N05AC04
- PIPOTIAZINE [INN]
- Pipotiazine (oxide)
- PIPOTIAZINE [MI]
- PIPOTIAZINE [MART.]
- PIPOTIAZINE [WHO-DD]
Look up PIPOTIAZINE in the interactive SynDRA portal →